Calendar Sarepta Therapeutics, Inc.

Equities

SRPT

US8036071004

Pharmaceuticals

Market Closed - Nasdaq Other stock markets 02:30:00 07/02/2026 am IST			5-day change	1st Jan Change
18.50 ^USD	+8.63%		-9.05%	-14.03%

04/02	Sarepta Therapeutics announces clinical trial application approval for SRP-1005 in Huntington's disease	RE
04/02	Sarepta Therapeutics Announces Approval of Clinical Trial Application for SRP-1005, Its Investigational Treatment for Huntington's Disease	CI

Chart calendar Sarepta Therapeutics, Inc.

e5be0c4d8ae2.i0S4BMl6Xm8osfcKUbS-BA5IGBUZKv3zQtKo_ruuZ0k.7x3gbI0ZKl5uiJpFZdKHV105SVBzGs7Eb5rEnPzxCSD4JtlloSAGDn_GnA~0b2b99782cc12625c617a7d13ea0b99c

Upcoming events on Sarepta Therapeutics, Inc.

03/03/2026	Q4 2025 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
06/05/2026	Q1 2026 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
05/08/2026	Q2 2026 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
04/11/2026	Q3 2026 Earnings Release (Projected)	Add to your calendar Google Apple ICS format

Past events on Sarepta Therapeutics, Inc.

26/01/2026	ELEVIDYS Phase 3 EMBARK Study Results Call
12/01/2026	J.P. Morgan Healthcare Conference
04/11/2025	Q3 2025 Earnings Call
04/11/2025	Q3 2025 Earnings Release
07/08/2025	Q2 2025 Earnings Release
18/07/2025	Business Update Call
17/07/2025	Business Update Call
16/06/2025	Business Update Call
05/06/2025	Annual General Meeting
17/05/2025	American Society of Gene & Cell Therapy Meeting
15/05/2025	American Society of Gene & Cell Therapy Meeting
14/05/2025	Bank of America Global Healthcare Conference
13/05/2025	American Society of Gene & Cell Therapy Meeting - Poster Number - 1353
13/05/2025	American Society of Gene & Cell Therapy Meeting - Poster Number - 1350
13/05/2025	American Society of Gene & Cell Therapy Meeting - Poster Number - 1422
07/05/2025	Q1 2025 Earnings Call
07/05/2025	Q1 2025 Earnings Release
27/02/2025	Q4 2024 Earnings Call
27/02/2025	Q4 2024 Earnings Release
27/01/2025	Business Update Call

Annual results

Fiscal Period	December	2022	2023	2024	2025	2026	2027
Net sales Million USD	Released Forecast Spread	933 925 0.86%	1 243 1 233 0.87%	1 902 1 842 3.26%	2 137	1 605	1 521
EBITDA Million USD	Released Forecast Spread	-494 -518 4.49%	-223 -278 19.63%	256 263 -2.59%	-363	338	364
EBIT Million USD	Released Forecast Spread	-536 -517 -3.66%	-268 -303 11.68%	218 180 21.06%	-414	311	304
Earnings before Tax (EBT) Million USD	Released Forecast Spread	-690 -708 2.57%	-520 -559 6.94%	261 271 -3.64%	-563	241	277
Net income Million USD	Released Forecast Spread	-703 -677 -3.95%	-536 -579 7.41%	235 256 -8.08%	-543	260	266
EPS USD	Released Forecast Spread	-8,03 -7,54 -6.49%	-5,80 -6,39 9.19%	2,34 2,68 -12.84%	-5,36	2,08	2,27
Announcement Date		28/02/23	28/02/24	26/02/25	-

Quarterly results

Fiscal Period	September	2024 Q1	2024 Q2	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4	2026 Q1	2026 Q2	2026 Q3	2026 Q4	2027 Q1	2027 Q2	2027 Q3
Net sales Million USD	Released Forecast Spread	413 375 10.13%	363 388 -6.42%	467 405 15.33%	658 631 4.34%	745 684 8.88%	611 531 15.07%	399 337 18.49%	391	377	377	391	416	421	415	410
EBITDA Million USD	Released Forecast Spread				172 222 -22.53%	-290 -371 21.73%	126 107 17.88%	-91,2 -93,4 2.4%	-144	46,8	77,4	116	201
EBIT Million USD	Released Forecast Spread	34,9 -18,3 290.45%	-0,70 -7,36 90.48%	22,2 -28,2 178.8%	162 182 -11.18%	-300 -247 -21.79%	116 90,4 27.81%	-103 -98,3 -5.18%	-136	38,5	54,8	71,1	99,6	46,0	83,0	83,0
Earnings before Tax (EBT) Million USD	Released Forecast Spread	41,4 -12,3 436.79%	13,6 1,02 1233.47%	34,0 -18,4 284.62%	172 191 -10.2%	-384 -219 -75.28%	154 87,9 74.71%	-194 -94,6 -105.1%	-131	35,6	61,8	70,9	104	50,0	87,0	87,0
Net income Million USD	Released Forecast Spread	36,1 -3,63 1094.49%	6,46 5,36 20.61%	33,6 -21,7 254.95%	159 190 -16.41%	-448 -253 -76.9%	197 82,3 139.15%	-180 -93,0 -93.43%	-126	19,5	43,3	70,6	96,6	40,0	69,6	69,6
EPS USD	Released Forecast Spread	0,37 0,02 2191.02%	0,07 0,00 3365.35%	0,34 -0,16 311.23%	1,50 1,88 -20.33%	-4,60 -1,53 -200.73%	1,89 0,67 180.35%	-1,80 -0,93 -93.47%	-1,25	0,27	0,46	0,60	0,71	0,38	0,65	0,64
Announcement Date		01/05/24	07/08/24	06/11/24	26/02/25	06/05/25	06/08/25	03/11/25	-	-	-	-	-	-	-	-

Upcoming sector events for Sarepta Therapeutics, Inc.

12/02/2026	ULTRAGENYX PHARMACEUTICAL INC.	Q4 2025 Earnings Release	Add to your calendar Google Apple ICS format
03/03/2026	SAREPTA THERAPEUTICS, INC.	Q4 2025 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
30/04/2026	ULTRAGENYX PHARMACEUTICAL INC.	Q1 2026 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
06/05/2026	SAREPTA THERAPEUTICS, INC.	Q1 2026 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
30/07/2026	ULTRAGENYX PHARMACEUTICAL INC.	Q2 2026 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
05/08/2026	SAREPTA THERAPEUTICS, INC.	Q2 2026 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
04/11/2026	SAREPTA THERAPEUTICS, INC.	Q3 2026 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
04/11/2026	ULTRAGENYX PHARMACEUTICAL INC.	Q3 2026 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
18/02/2027	ULTRAGENYX PHARMACEUTICAL INC.	Q4 2026 Earnings Release (Projected)	Add to your calendar Google Apple ICS format

More events

Past sector events for Sarepta Therapeutics, Inc.

05/11/2025	ULTRAGENYX PHARMACEUTICAL INC.	Q3 2025 Earnings Release
04/11/2025	SAREPTA THERAPEUTICS, INC.	Q3 2025 Earnings Release
07/08/2025	SAREPTA THERAPEUTICS, INC.	Q2 2025 Earnings Release
06/08/2025	ULTRAGENYX PHARMACEUTICAL INC.	Q2 2025 Earnings Release
07/05/2025	SAREPTA THERAPEUTICS, INC.	Q1 2025 Earnings Release
07/05/2025	ULTRAGENYX PHARMACEUTICAL INC.	Q1 2025 Earnings Release